Integrating Clinical Research And Care In A Perpetual Trial This is the wave of the future. It combines everything needed to speed up the search for the cure: finding the best treatments for each individual patient, helping them to get access, and analyzing the results so we learn from each patient. Instead of trying to find the right patients for a specific treatment, this turns it around and finds the best treatment for a specific patient.
The Musella Foundation is partnering with xCures and Cancer Commons to run compassionate use programs in a new way where we collect the real world data to help speed up drug approvals and learn best how to use drugs.
Disclaimer: I own stock in xCures, and am a consultant for them.
Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma. As expected, the better insurance you have the better you will do. This is very significant when we start talking about Medicare for all. The most popular "medicare for all" plan really is Medicaid for all. It sounds good with no copayments or deductibles, but when you try to limit costs especially for complex cases like a brain tumor, quality has to suffer.
One fault in the article- it says Medicare patients do not live as long as private insurance payments, but they did not correct for age. Medicare patients are usually older than private insurance patients, especially at the time of the first surgery. Older people in general do not do as well as younger people.
